Perpetual Ltd’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.1M Sell
5,916
-27,027
-82% -$27.6M 0.1% 122
2026
Q1
$30.3M Sell
32,943
-1,227
-4% -$1.24M 0.46% 56
2025
Q4
$36.7M Buy
34,170
+31,434
+1,149% +$30.1M 0.53% 46
2025
Q3
$2.09M Buy
2,736
+1,236
+82% +$920K 0.03% 185
2025
Q2
$1.17M Buy
1,500
+100
+7% +$77.7K 0.01% 233
2025
Q1
$1.16M Sell
1,400
-91,771
-98% -$76.4M 0.01% 233
2024
Q4
$71.9M Sell
93,171
-4,301
-4% -$3.56M 0.84% 44
2024
Q3
$86.4M Sell
97,472
-4,085
-4% -$3.67M 0.94% 34
2024
Q2
$91.9M Sell
101,557
-18,319
-15% -$14.7M 1% 31
2024
Q1
$93.3M Sell
119,876
-31,210
-21% -$22.2M 0.91% 35
2023
Q4
$88.1M Buy
151,086
+146,973
+3,573% +$85.8M 0.91% 33
2023
Q3
$2.21M Buy
4,113
+426
+12% +$220K 0.02% 205
2023
Q2
$1.73M Sell
3,687
-171
-4% -$71.7K 0.01% 253
2023
Q1
$1.32M Buy
+3,858
New +$1.3M 0.01% 287
2020
Q3
$844K Hold
5,700
0.06% 195
2020
Q2
$936K Buy
+5,700
New +$875K 0.09% 139
2020
Q1
Sell
-5,700
Closed -$748K 215
2019
Q4
$748K Hold
5,700
0.11% 86
2019
Q3
$637K Hold
5,700
0.1% 89
2019
Q2
$632K Sell
5,700
-2,500
-30% -$294K 0.1% 86
2019
Q1
$1.06M Hold
8,200
0.15% 73
2018
Q4
$936K Hold
8,200
0.14% 76
2018
Q3
$880K Sell
8,200
-3,300
-29% -$330K 0.12% 82
2018
Q2
$983K Buy
11,500
+2,100
+22% +$172K 0.12% 80
2018
Q1
$727K Hold
9,400
0.1% 82
2017
Q4
$801K Buy
9,400
+800
+9% +$68.1K 0.1% 86
2017
Q3
$741K Hold
8,600
0.1% 84
2017
Q2
$708K Hold
8,600
0.06% 185
2017
Q1
$734K Buy
+8,600
New +$689K 0.07% 122
2016
Q4
Sell
-7,147
Closed -$574K 183
2016
Q3
$574K Sell
7,147
-12,078
-63% -$967K 0.05% 190
2016
Q2
$1.51M Buy
19,225
+1,200
+7% +$90.3K 0.15% 118
2016
Q1
$1.3M Sell
18,025
-1,500
-8% -$113K 0.13% 119
2015
Q4
$1.65M Buy
19,525
+2,600
+15% +$216K 0.18% 102
2015
Q3
$1.42M Sell
16,925
-1,700
-9% -$144K 0.17% 101
2015
Q2
$1.55M Sell
18,625
-2,800
-13% -$213K 0.18% 101
2015
Q1
$1.56M Hold
21,425
0.18% 102
2014
Q4
$1.48M Buy
21,425
+800
+4% +$54K 0.17% 135
2014
Q3
$1.34M Sell
20,625
-3,000
-13% -$190K 0.14% 128
2014
Q2
$1.47M Buy
23,625
+3,000
+15% +$179K 0.13% 121
2014
Q1
$1.21M Sell
20,625
-4,000
-16% -$223K 0.18% 116
2013
Q4
$1.26M Sell
24,625
-3,339
-12% -$167K 0.17% 114
2013
Q3
$1.41M Sell
27,964
-25,482
-48% -$1.33M 0.2% 106
2013
Q2
$2.63M Buy
+53,446
New +$2.91M 0.39% 60

Other funds holding LLY

Perpetual Ltd's LLY Position: Q2 2026 in Review

Perpetual Ltd reduced its Eli Lilly (LLY) stake by 82% in Q2 2026, selling an estimated $27.6M and leaving 5,916 shares worth $7.1M. The position accounts for 0.1% of the portfolio, ranked #122.

Perpetual Ltd first reported a position in LLY in Q2 2013 and has held it in 42 quarters since. The position peaked at $93.3M in Q1 2024. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Perpetual Ltd held 5,916 shares of Eli Lilly worth $7.1M as of Q2 2026.
  • Perpetual Ltd sold 27,027 Eli Lilly shares in Q2 2026, an estimated $27.6M.
  • Eli Lilly made up 0.1% of Perpetual Ltd's portfolio in Q2 2026, its #122 holding.
  • Perpetual Ltd first reported a position in Eli Lilly in Q2 2013 and has held it in 42 quarters since.
  • Perpetual Ltd's Eli Lilly position peaked at $93.3M in Q1 2024.
  • 1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.